Search bioRxiv⌕ Search

Biology subjects

Piggins, H.

Publications and source records attributed to Piggins, H..

2 recordsLinked to original sources

Circadian rhythm in the atrioventricular node - in electrophysiology, contractility, metabolism, intracellular signalling and extracellular matrix

The atrioventricular (AV) node shows a circadian rhythm-during sleep the PR interval is longer (because conduction velocity is decreased) and AV block is more common. We show the rhythm is similar in mouse and human, and using mice we have investigated the cause. There was still a rhythm in Kcnj5 knockout mice ruling out a major role of vagal tone (the vagus regulates the node via Kcnj5). Instead, we show the presence of a functioning circadian clock in the node (e.g. by detection of rhythmic clock transcripts). There was ~43-52% reduction in the rhythm of the PR interval on inhibition of the clock in a Bmal1 knockout mouse. There was a significant rhythm in >300 intracellular signalling molecules presumably driven by the clock and perhaps extrinsic signals. Downstream of the clock and signalling molecules, there was a rhythm in many transcripts and proteins (of 4,186 proteins, ~15% had a rhythm), responsible for example for contractile machinery, metabolism, extracellular matrix, and importantly ion channels. Ultimately, the PR interval is determined by ion channels, and there were rhythms in ion channels and ionic currents. A key determinant of conduction velocity is the upstroke velocity of the Ca2+-dependent nodal action potential and this was significantly reduced during sleep, this can be explained by reduced expression of Ca2+ channel subunits and a smaller L-type Ca2+ current at this time and this was confirmed by biophysically-detailed computer modelling. In conclusion, there is day-night molecular remodelling of the AV node and this is largely responsible for the circadian rhythm in the PR interval.

physiology↗

Design and validation of the first family of photo-activatable ligands for melatonin receptors

Melatonin is a neurohormone released in a circadian manner with peak levels during the night. In mammals, melatonin mediates its effects mainly through G protein-coupled MT1 and MT2 receptors. Drugs acting on melatonin receptors are indicated for circadian rhythm- and sleep-related disorders and major depression. Pharmacological tools to study the activation of these receptors with high temporal resolution are lacking. Here, we synthesized a family of light-activatable caged melatonin compounds by covalently attaching o-nitrobenzyl (o-NB) or coumarin photocleavable groups to the N-position of melatonin. All caged compounds showed the expected decrease in binding affinity for MT1 and MT2. Among them, the o-NB derivative MCS-0382 showed the best uncaging and biological properties upon light activation with a significant increase (2.5 log left-shift) in affinity and potency in melatonin receptor binding and signaling, respectively. Generation of biologically active melatonin from MCS-0382 was further demonstrated by its ability to modulate the excitation of SCN neurons in rat brain slices. MCS-0382 is now available to study melatonin effects in a temporally controlled manner in cellular and physiological settings.

pharmacology and toxicology↗